AzTrials
AzTrials

PainNCT01461031

Effect of Nefopam on Acute Postoperative Pain in Patients Undergoing Orthognathic Surgery

A study testing nefopam in people with Pain and Orthognathic Surgery, run by The Catholic University of Korea at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine the analgesic effect of perioperative nefopam on acute pain in patient undergoing orthognathic surgery. Read more about this study

Who is it for?
Ages 20 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Pain, Orthognathic Surgery
What is being tested?
nefopam
Type of treatment
Injection or infusion
How many people
40 participants
Where
1 siteSouth Korea
Study dates
Oct 2011to Sep 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • aged 20-60 years
  • undergoing elective orthognathic surgery

Who cannot join

  • pregnancy
  • psychiatric disease
  • hepatobiliary or renal disease
  • monoamine oxidase inhibitor-taking patients

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul St.Mary's Hospital

    Seoul, Seocho-gu, 137-701

Other trials in South Korea

About this study

The aim of this study is to determine the analgesic effect of perioperative nefopam on acute pain in patient undergoing orthognathic surgery.

Being tested
nefopam, normal saline (control)
Keywords
pain, orthognathic
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • nefopamDrug

    nefopam infusion for postoperative 24 hours

  • normal saline (control)Drug

    normal saline infusion for postoperative 24 hours

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain score on the visual analogue scale

    Measured: after orthognathic surgery (up to postoperative 24 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2011 (estimated)
  2. Study startOct 2011
  3. Primary completionSep 2012
  4. Study completionSep 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Single group
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01461031
Sponsor's protocol ID
nefopam-orthognathic
Status last verified
Feb 2021
First submitted
11 Oct 2011
Last updated
4 Feb 2021
Results posted
No
Data monitoring committee
Yes

Publications

  • Park HJ, Park JU, Yoo W, Moon YE. Analgesic effects of nefopam in patients undergoing bimaxillary osteotomy: A double-blind, randomized, placebo-controlled study. J Craniomaxillofac Surg. 2016 Feb;44(2):210-4. doi: 10.1016/j.jcms.2015.11.012. Epub 2015 Dec 1.

    PubMed 26725583

Questions about this trial

What is this clinical trial studying?

A study testing nefopam in people with Pain and Orthognathic Surgery, run by The Catholic University of Korea at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain score on the visual analogue scale (time frame: after orthognathic surgery (up to postoperative 24 hours)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01461031, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in